| Date Filed | Type | Description |
| 06/09/2023 |
4
| Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Bought 422 shares
@ $3.3576, valued at
$1.4k
Bought 2,859 shares
@ $3.4, valued at
$9.7k
Bought 11,719 shares
@ $3.4395, valued at
$40.3k
|
|
| 06/06/2023 |
4
| Gengos Andrew (See Below) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Bought 10,012 shares
@ $2.75, valued at
$27.5k
Bought 6,582 shares
@ $2.8598, valued at
$18.8k
Bought 3,418 shares
@ $2.945, valued at
$10.1k
Bought 15,000 shares
@ $3, valued at
$45k
Bought 10,000 shares
@ $2.9997, valued at
$30k
Bought 10,000 shares
@ $2.9999, valued at
$30k
Bought 10,000 shares
@ $3.0154, valued at
$30.2k
|
|
| 06/06/2023 |
4
| MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 7,764 shares
@ $2.41, valued at
$18.7k
Exercised 7,882 options to buy
@ $1.35, valued at
$10.6k
|
|
| 03/31/2023 |
4
| PICKERING GRANT (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Bought 10,000 shares
@ $2.33, valued at
$23.3k
Bought 15,000 shares
@ $2.47, valued at
$37.1k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2023 |
4
| Worthington Mark (General Counsel) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.37, valued at
$505.5k
|
|
| 01/23/2023 |
4
| MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.37, valued at
$674k
|
|
| 01/23/2023 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.37, valued at
$505.5k
|
|
| 01/23/2023 |
4
| Lenington Rachel (COO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.37, valued at
$674k
|
|
| 01/23/2023 |
4
| CHURCH KEVIN (Executive VP, Research) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 657 shares
@ $2.74, valued at
$1.8k
Granted 150,000 options to buy
@ $3.37, valued at
$505.5k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| MOEBIUS HANS (Chief Medical Officer) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Exercised 7,881 options to buy
@ $1.35, valued at
$10.6k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Lenington Rachel (COO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Sold 4,193 shares
@ $2.69, valued at
$11.3k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| PICKERING GRANT (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 3,467 options to buy
@ $8.93, valued at
$31k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Kosacz Barbara (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 13,871 options to buy
@ $8.93, valued at
$123.9k
|
|
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| MILESON GLENNA (CFO) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Exercised 3,000 options to buy
@ $10.64, valued at
$31.9k
|
|
|